We believe AI augmented bio-engineering will design the cures of tomorrow
Cells are the most advanced piece of engineering on earth resulting from trillions of chemical interactions. However, small perturbations within those interactions, due to mutations or external influences, can lead cells to pathological states, then causing diseases.
For decades, biologists have struggled to identify those causes by iteratively reconstructing cell mechanisms.
At DeepLife, we develop novel approaches based on state-of the art multi-omics data, machine learning, and systems engineering to identify molecular triggers driving back a cell in its healthy state.
Access harmonized, ML ready multi-omics datasets from 30+ qualified data repositories
Subscribe to up to date, continuously curated organ and disease atlases
Acquire your data in one click with API driven interoperable data packages
Run large-scale analysis on 10M cells seamlessly in a flexible coding environment
Integrate state-ot-the-art analysis tools using R & Python toolboxes
Stay up to date with 24/7 best in class verified and executable tools (24/7 support)
Identify & prioritize druggable targets and biomarkers
Perform comprehensive pathway analysis
Run large scale training for diseases specific cell models
Access harmonized, ML ready multi-omics datasets from 30+ qualified data repositories
Subscribe to up to date, continuously curated organ and disease atlases
Acquire your data in one click with API driven interoperable data packages
Run large-scale analysis on 10M cells seamlessly in a flexible coding environment
Integrate state-ot-the-art analysis tools using R & Python toolboxes
Stay up to date with 24/7 best in class verified and executable tools (24/7 support)
Identify & prioritize druggable targets and biomarkers
Perform comprehensive pathway analysis
Run large scale training for diseases specific cell models
Deciphering cell behaviour together
At DeepLife, we enable our partners to leverage the power of our AI discovery platform to unlock biological insights and generate innovative novel treatments for diverse disease domains. We foster partnerships around two forms: assets development or discovery platform partnerships.
Partner with usOur partners